These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20846038)

  • 1. Viral evolution and escape during acute HIV-1 infection.
    Boutwell CL; Rolland MM; Herbeck JT; Mullins JI; Allen TM
    J Infect Dis; 2010 Oct; 202 Suppl 2(Suppl 2):S309-14. PubMed ID: 20846038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
    Fischer W; Ganusov VV; Giorgi EE; Hraber PT; Keele BF; Leitner T; Han CS; Gleasner CD; Green L; Lo CC; Nag A; Wallstrom TC; Wang S; McMichael AJ; Haynes BF; Hahn BH; Perelson AS; Borrow P; Shaw GM; Bhattacharya T; Korber BT
    PLoS One; 2010 Aug; 5(8):e12303. PubMed ID: 20808830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
    Yue L; Pfafferott KJ; Baalwa J; Conrod K; Dong CC; Chui C; Rong R; Claiborne DT; Prince JL; Tang J; Ribeiro RM; Cormier E; Hahn BH; Perelson AS; Shaw GM; Karita E; Gilmour J; Goepfert P; Derdeyn CA; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Jan; 11(1):e1004565. PubMed ID: 25569444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and Factors That Drive Extensive Human Immunodeficiency Virus Type-1 Hypervariability: An Overview.
    Yaseen MM; Abuharfeil NM; Alqudah MA; Yaseen MM
    Viral Immunol; 2017 Dec; 30(10):708-726. PubMed ID: 29064351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution and Diversity of HIV-1].
    Metzner KJ
    Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
    O'Connor D; Allen T; Watkins DI
    Immunol Lett; 2001 Nov; 79(1-2):77-84. PubMed ID: 11595292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.
    Hraber P; Korber B; Wagh K; Giorgi EE; Bhattacharya T; Gnanakaran S; Lapedes AS; Learn GH; Kreider EF; Li Y; Shaw GM; Hahn BH; Montefiori DC; Alam SM; Bonsignori M; Moody MA; Liao HX; Gao F; Haynes BF
    Viruses; 2015 Oct; 7(10):5443-75. PubMed ID: 26506369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
    Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
    mBio; 2017 May; 8(3):. PubMed ID: 28465428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on HIV-1 immune escape mechanisms.
    Meng Y; Zhong J; Lv Y; Zou W
    AIDS Rev; 2022 Oct; 24(3):133-138. PubMed ID: 35504029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of viral evolution and CTL responses in HIV-1 infection.
    Liu Y; McNevin JP; Holte S; McElrath MJ; Mullins JI
    PLoS One; 2011 Jan; 6(1):e15639. PubMed ID: 21283794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-epidemiological modeling of HIV-1 predicts high heritability of the set-point virus load, while selection for CTL escape dominates virulence evolution.
    van Dorp CH; van Boven M; de Boer RJ
    PLoS Comput Biol; 2014 Dec; 10(12):e1003899. PubMed ID: 25522184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 mutates to adapt in fluxing environments.
    Nomaguchi M; Doi N; Koma T; Adachi A
    Microbes Infect; 2018; 20(9-10):610-614. PubMed ID: 28859896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
    Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
    PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
    Moore PL; Williamson C; Morris L
    Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.